To the full analysis
Balchem stock: growth
BCPCBalchem reported $1.04B in revenue for fiscal 2025, up 8.8% on the prior year, up 8.1% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
13%
per year from 2006 to 2025, per share 11.8%
Earnings (Annual rate)
14.3%
per year from 2006 to 2025, per share 13%
Free cash flow (Annual rate)
14.1%
per year from 2006 to 2025, per share 12.9%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 8.1% | 6.5% | 13.0% |
| Revenue per share | 7.8% | 6.0% | 11.8% |
| Earnings | 12.8% | 10.0% | 14.3% |
| Earnings per share | 12.8% | 9.6% | 13.0% |
| Free cash flow | 8.2% | 10.9% | 14.1% |
| Free cash flow per share | 7.9% | 10.4% | 12.9% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $100.91M | $12.28M | $14.01M |
| 2007 | $176.2M | $16.12M | $10.6M |
| 2008 | $232.05M | $19.05M | $17.64M |
| 2009 | $219.44M | $26.79M | $44.43M |
| 2010 | $255.07M | $33.28M | $31.47M |
| 2011 | $291.87M | $38.77M | $38.27M |
| 2012 | $310.39M | $40.01M | $39.78M |
| 2013 | $337.17M | $44.87M | $47.28M |
| 2014 | $541.38M | $52.83M | $71.98M |
| 2015 | $552.49M | $59.72M | $61.52M |
| 2016 | $553.2M | $55.97M | $83.62M |
| 2017 | $594.79M | $90.07M | $82.52M |
| 2018 | $643.68M | $78.57M | $98.97M |
| 2019 | $643.71M | $79.67M | $96.05M |
| 2020 | $703.64M | $84.62M | $116.67M |
| 2021 | $799.02M | $96.1M | $123.07M |
| 2022 | $942.36M | $105.37M | $88.25M |
| 2023 | $922.44M | $108.54M | $145.87M |
| 2024 | $953.68M | $128.48M | $146.34M |
| 2025 | $1.04B | $154.85M | $173.07M |
Revenue by region
Where Balchem Corp generates its revenue.
- United States73%
- Outside the US27%
Figures as a table
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| United States | $482.69M | $475.03M | $516.35M | $584.66M | $682.24M | $689.6M | $723.3M | $759.45M | 73.2% |
| Outside the US | $160.99M | $168.67M | $187.3M | $214.36M | $260.12M | $232.84M | $230.38M | $277.71M | 26.8% |
| Total revenue | $643.68M | $643.71M | $703.64M | $799.02M | $942.36M | $922.44M | $953.68M | $1.04B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 30 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.